Sort
64,565 grants matching “drug discovery”
Small molecule mitochondria-targeted therapeutics for AD
$785,056Eugenia Trushina · Mayo Clinic Rochester · UG3 · FY2021 · NS
Entry and replication of positive-sense, RNA viruses
$785,051Joseph Marcotrigiano · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI
Making the HIV-1 gp41 pocket amenable to small-molecule drug discovery
$785,000Peter S Kim · Stanford University · DP1 · FY2019 · DA
Making the HIV-1 gp41 pocket amenable to small-molecule drug discovery
$785,000Peter S Kim · Stanford University · DP1 · FY2017 · DA
Making the HIV-1 gp41 pocket amenable to small-molecule drug discovery
$785,000Peter S Kim · Stanford University · DP1 · FY2021 · DA
Making the HIV-1 gp41 pocket amenable to small-molecule drug discovery
$785,000Peter S Kim · Stanford University · DP1 · FY2018 · DA
Making the HIV-1 gp41 pocket amenable to small-molecule drug discovery
$785,000Peter S Kim · Stanford University · DP1 · FY2020 · DA
Synthetic Biology Platforms for Natural Product Discovery and Biosynthesis
$785,000Christina D Smolke · Stanford University · DP1 · FY2014 · AT
Synthetic Biology Platforms for Natural Product Discovery and Biosynthesis
$785,000Christina D Smolke · Stanford University · DP1 · FY2016 · AT
Synthetic Biology Platforms for Natural Product Discovery and Biosynthesis
$785,000Christina D Smolke · Stanford University · DP1 · FY2015 · AT
Synthetic Biology Platforms for Natural Product Discovery and Biosynthesis
$785,000Christina D Smolke · Stanford University · DP1 · FY2012 · AT
Development of GCPII inhibitors for the treatment of age-related cognitive disorders
$784,969Takashi Tsukamoto · Johns Hopkins University · R01 · FY2024 · AG
Clinical and Translational Science Award
$784,809Robert Stanley Sherwin · Yale University · KL2 · FY2009 · RR
Drug Discovery for Human African Trypanosomiasis
$784,716Michael H Gelb · University Of Washington · R01 · FY2017 · AI
Investigating nanobodies to target multidrug resistant bacterial pathogens
$784,687Bryan William Davies · University Of Texas At Austin · R01 · FY2020 · AI
Nicotinic Ligands for Smoking Cessation
$784,670Henry A. Lester · California Institute Of Technology · U19 · FY2011 · DA
Development of GCPII inhibitors for the treatment of age-related cognitive disorders
$784,616Takashi Tsukamoto · Johns Hopkins University · R01 · FY2023 · AG
Mechanisms of Prion Protein Toxicity
$784,573David A Harris · Boston University Medical Campus · R01 · FY2022 · NS
Drug Development for Prostate Cancer and other Metastatic Processes
$784,504William Douglas Figg · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Engineering biophysical microtechnologies for hematologic applications in health and disease
$784,500Wilbur A Lam · Emory University · R35 · FY2023 · HL
Structural Studies of Opioid Receptors, p 55
$784,494Vadim Cherezov · University Of Southern California · P01 · FY2016 · DA
Development of a Mirror-Image Natural Product as an Antiarrhythmic Therapeutic
$784,438Jeffrey Nicholas Johnston · Vanderbilt University · R01 · FY2021 · HL
Project 2: Development of Small Molecule Inhibitors of IL-17A Pathway for Treatment of Severe Asthma
$784,421Serpil C. Erzurum · Cleveland Clinic Lerner Com-Cwru · P01 · FY2020 · HL
Project 2: Development of Small Molecule Inhibitors of IL-17A Pathway for Treatment of Severe Asthma
$784,421Xiaoxia Li · Cleveland Clinic Lerner Com-Cwru · P01 · FY2019 · HL
Uncovering novel biological processes and pathogenic mechanisms for glaucoma
$784,373Ayellet Vered Segre · Massachusetts Eye And Ear Infirmary · R01 · FY2020 · EY